AMENDED AND RESTATED SECOND AMENDMENT TO LETTER AGREEMENTSecond Amendment to Letter Agreement • February 28th, 2022 • Mirati Therapeutics, Inc. • Pharmaceutical preparations
This Amended and Restated Second Amendment to Letter Agreement (this “Amendment”) is entered into by Mirati Therapeutics, Inc., a Delaware corporation (the “Company”), and James Christensen, Ph.D. (“Employee” or “you”) and shall be effective as of September 20, 2021.
Daniel Faga La Jolla, CA 92037 Re: Separation Agreement and Release Dear Dan:Separation Agreement • February 28th, 2022 • Mirati Therapeutics, Inc. • Pharmaceutical preparations
This letter sets forth the substance of the separation agreement (the “Agreement”) that Mirati Therapeutics, Inc. (the “Company”) is offering to aid in your employment transition. The Agreement shall become effective upon the Effective Date as defined in Paragraph 16 below.
